BiomarkersHuman trial
Tasks discriminating cognitive impairment levels: Item Response Theory applied to the Alzheimer's Disease Assessment Scale Cognitive Subscale
AAIC 2025 Abstract
Abstract
Background: Since cognitive impairment is a clinical hallmark of Alzheimer's disease, suitable assessments are essential for treatment and research following onset. The most widely used and researched cognitive impairment measure in clinical trials of Alzheimer's Disease is the Alzheimer's Disease Assessment Scale Cognitive Subscale.
The paper
Anat Rotstein, Stephen Z. Levine, Yair Goldberg, Toshiaki A. Furawaka
Show 5 more authors
Myrto T. Samara, Kazufumi Yoshida, Andrea Cipriani, Takeshi Iwatsubo, Stefan Leucht,University of Haifa · Kyoto University
AAIC 2025 Abstract · 24 Dec 2025 · CC BY
Presented at AAIC 2025